Management of sarcomas of the head and neck

Current Oncology Reports

Volumn 6, Issue 4, 2004, Pages 321-327

  Brockstein, Bruce ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; IMATINIB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; SULINDAC; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

ANGIOSARCOMA; BONE TRANSPLANTATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHONDROSARCOMA; DERMATOFIBROSARCOMA PROTUBERANS; DESMOID TUMOR; DISEASE COURSE; EVIDENCE BASED MEDICINE; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; LARYNGECTOMY; LARYNX CANCER; LEIOMYOSARCOMA; MEDICAL LITERATURE; NERVE SHEATH TUMOR; OSTEOSARCOMA; PATIENT CARE; PROGNOSIS; REVIEW; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TUMOR LOCALIZATION; UNITED STATES;

EID: 5444258243     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-004-0043-0     Document Type: Review

References (47)

1. American Cancer Society: Cancer facts and figures 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf Accessed February 6, 2004.
2. Desai J, Demetri GD: Gastrointestinal stromal tumors: a paradigm for translational research in solid tumors. Prin Pract Oncol 2002, 16:1-10.
3. Wanebo HJ, Koness RJ, MacFarlane JK, et al.: Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 1992, 14:1-7.
4. Odell PF: Head and neck sarcomas: a review. J Otolaryngol 1996, 25:7-13.
5. Eeles RA, Fisher C, A'Hern RP, et al.: Head and neck sarcomas: prognostic factors and implications for treatment. Br J Cancer 1993, 68:201-207.
6. Weber RS, Benjamin RS, Peters LJ, et al.: Soft tissue sarcomas of the head and neck in adolescents and adults. Am J Surg 1986, 152:386-392.
7. Kowalski LP, San CI: Prognostic factors in head and neck soft tissue sarcomas: analysis of 128 cases. J Surg Oncol 1994, 56:83-88.
8. Freedman AM, Reiman HM, Woods JE: Soft-tissue sarcomas of the head and neck. Am J Surg 1989, 158:367-372.
9. Farhood AI, Hajdu SI, Shiu MH, Strong EW: Soft tissue sarcomas of the head and neck in adults. Am J Surg 1990, 160: 65-369.
10. Figueiredo MT, Marques LA, Campos-Filho N: Soft-tissue sarcomas of the head and neck in adults and children: experience at a single institution with a review of literature. Int J Cancer 1988, 41:198-200.
11. Greager JA, Das Gupta TK: Adult head and neck soft-tissue sarcomas. Otolaryngol Clin North Am 1986, 19:565-572.
12. Rao BN, Santana VM, Fleming ID, et al.: Management and prognosis of head and neck sarcomas. Am J Surg 1989, 158: 73-377.
13. Kraus DH, Dubner S, Harrison LB, et al.: Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer 1994, 74:697-702.
14. Zagars GK, Ballo MT, Pisters PW, Pollock RE: Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 2003, 97:2530-2543.
15. Yang JC, Chang AE, Baker AE, et al.: Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 1998, 16:197-203.
16. Alektiar KM, Leung D, Zelefsky MJ, Brennan MF: Adjuvant radiation for stage II-B soft tissue sarcoma of the extremity. J Clin Oncol 2002, 20:1643-1650.
17. Baker JL Jr, Paulino AC, Feeney S, et al.: Locoregional treatment for adult soft tissue sarcomas of the head and neck: an institutional review. Cancer J 2003, 9:49-57.
18. Patel SG, Meyers P, Huvos AG, et al.: Improved outcome in patients with osteogenic sarcoma of the head and neck. Cancer 2002, 95:1495-1503.
19. Thompson LDR, Gannon FH: Chondrosarcoma of the larynx: a clinicopathologic study of 111 cases with a review of the literature. Am J Surg Path 2002, 26:836-851.
20. Ward JR, Feigenberg SJ, Price Mendenhall N, et al.: Radiation therapy for angiosarcoma. Head Neck 2003, 25: 73-878.
21. Sasaki R, Soejima T, Kishi K, et al.: Angiosarcoma treated with radiotherapy: impact of tumor type and size on outcome. Int J Radiat Oncol Biol Phys 2002, 52:1032-1040.
22. Lydiatt WM, Shaha AR, Shah JP: Angiosarcoma of the head and neck. Am J Surg 1994, 168:451-454.
23. Holden CA, Spittle MF, Wilson Jones E: Angiosarcoma of the face and scalp: prognosis and treatment. Cancer 1987, 59: 046-1057.
24. Mark RJ, Tran LM, Sercarz J, et al.: Angiosarcoma of the head and neck: the UCLA experience 1955 through 1990. Arch Otolaryngol Head Neck Surg 1993, 119:973-978.
25. Panje WR, Moran WJ, Bostwick DG, Kitt VV: Angiosarcoma of the head and neck: review of 11 cases. Laryngoscope 1986, 96: 381-1384.
26. Aust MR, Olsen KD, Lewis JE, et al.: Angiosarcomas of the head and neck: clinical and pathologic characteristics. Ann Otol Rhinol Laryngol 1997, 106:943-951.
27. Fata F, O'Reilly E, Ilson D, et a.l: Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999, 86:2034-2037.
28. Crist W, Gehan EA, Ragab AH, et al.: The third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 1995, 13: 10-630.
29. Hawkins DS, Anderson JR, Paidas CN, et al.: Improved outcome for patients with middle ear rhabdomyosarcoma: a Children's Oncology Group study. J Clin Oncol 2001, 19:3073-3079.
30. Wharam MD Jr, Foulkes MA, Lawrence W Jr, et al.: Soft tissue sarcoma of the head and neck in childhood: nonorbital and nonparameningeal sites: a report of the Intergroup Rhabdomyosarcoma Study (IRS)-I. Cancer 1984, 53:1016-1019.
31. Nayar RC, Prudhomme F, Parise O Jr, et al. ]: Rhabdomyosarcoma of the head and neck in adults: a study of 26 patients. Laryngoscope 1993, 103:1362-1366.
32. Callender TA, Weber RS, Janjan N, et al.: Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg 1995, 112:252-257.
33. Prestidge BR, Donaldson SS: Treatment results among adults with childhood tumors: a 20-year experience. Int J Radiat Oncol Biol Phys 1989, 17:507-514.
34. Maurer HM, Beltangady M, Gehan EA, et al.: The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 1988, 61:209-220.
35. Maurer HM, Gehan EA, Beltangady M, et al.: The Intergroup Rhabdomyosarcoma Study-II. Cancer 1993, 71: 904-1922.
36. Raney RB, Asmar L, Vassilopoulou-Sellin R, et al.: Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: a descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and -III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol 1999, 33:362-371.
37. Raney RB, Anderson JR, Kollath J, et al.: Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. Med Pediatr Oncol 2000, 34:413-420.
38. Hoos A, Lewis JJ, Urist MJ, et al.: Desmoid tumors of the head and neck: a clinical study of a rare entity. Head Neck 2000, 22:814-821.
39. Ballo MT, Zagars GK, Pollack A, et al.: Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy or combined surgery and radiation therapy. J Clin Oncol 1999, 17:158-167.
40. Mace J, Sybil Biermann J, et al.: Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 2002, 95:2373-9.
41. Gloster HM Jr, Harris KR, Roenigk RK: A comparison between Moh's micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996, 35:82-87.
42. Ah-Weng A, Marsden JR, Sanders DS, Waters R: Dermatofibrosarcoma protuberans treated by micrographic surgery. Br J Cancer 2002, 87:1386-1389.
43. Tom WD, Hybarger CP, Rasgon BM: Dermatofibrosarcoma protuberans of the head and neck: treatment with Moh's surgery using inverted horizontal paraffin sections. Laryngoscope 2003, 113:1289-1293.
44. Maki RG, Awan RA, Dixon RH, et al.: Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int J Cancer 2002, 100: 23-626.
45. Rubin BP, Schuetze SM, Eary JF, et al.: Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J Clin Oncol 2002, 20:3586-3591.
46. McArthur GA, Demetri GD, Heinrich M, et al.: Molecular and clinical analysis of response to imatinib for locally advanced dermatofibrosarcoma protuberans [abstract]. Proc ASCO 2003, 22:195a.
47. Scudder CL: Tumors of the Jaws. Philadelphia: WB Saunders; 1912.